drugset
Drugs / Bacillus thuringiensis israelensis
last change Mar 2025 re-read 9 days ago

Bacillus thuringiensis israelensis

also known as Bti
Developed for
Plasmodium falciparum malaria
Investigated by
Mbarara University of Science and Technology · National Institute of Allergy and Infectious Diseases (NIAID) · North Carolina State University · University of North Carolina, Chapel Hill

Trials 1

today NCT06870344 · not/applicable
2026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT06870344 Mar 2025 → Oct 2026 expected Plasmodium falciparum malaria University of North Carolina, Chapel Hill Active not recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Bacillus thuringiensis israelensis ClinicalTrials.gov intervention name — accepted as the source's own label NCT06870344 ↗
Known as Bti “The biologic larvicide Bacillus thuringiensis israelensis (Bti) is non-toxic to mammals, birds, and fish.” NCT06870344 ↗